Target organs in arterial hypertension

Abstract

One of the consequences of long-term BP increase is damage of internal organs, the so-called target organs (target organ damage, end organ damage). These include heart, brain, kidneys, vessels. Heart damage in arterial hypertension may be manifested by left ventricular hypertrophy, angina pectoris, myocardial infarction, chronic heart failure and sudden death, brain damage - by thrombosis and hemorrhages, hypertensive encephalopathy and cerebral lacunae, kidneys - microalbuminuria, proteinuria, chronic renal failure, vascular involvement - lesions of retinal vessels, carotid arteries, aorta (aneurysm).

Keywords

Kazan Medical archive

References

[1] Алмазов В. А., Шляхто Е.В., Соколова Л.А. Пограничная артериальная гипертензия. — СПб, 1992.

[2] Aalkjaer С., Heagerty А.М. et al.// Cirс. Res. — 1987. - Vol. 61. - P. 181-186.

[3] Agewall S., Wikstrand J. et al.// Am. J. Hypertens. - 1995. - Vol. 8. - P. 337-342.

[4] Bauer J. H, Reams G.P., Wu Z.// Am. J. Med. — 1991. - Vol. 90.- P. 21S-27S.

[5] Baumbach G.L., Heistad D.D.// Hypertension. — 1989. - Vol. 13. - P. 968-972.

[6] Bianchi S., Bigazzi R. et al.// Am. J. Hypertens. - 1994. - Vol. 7. — P. 23-29.

[7] Brush J.E., Cannon R.O. et al.// N. Engl. J. Med. - 1988. - Vol. 319. - P. 1302-1307.

[8] Christensen K.L., Mulvany M. J.// J. Vase. Res. — 1993. - Vol. 30. - P. 73-79.

[9] de Leeuw P. IK//Am. J. Med. — 1966. — Vol. 90. — P. 45S- 49S.

[10] de Leeuw P. W., Gaillard C.A., Birkenhager W.H. The Kidney in Hypertension. In: Swales J.D. (ed), Textbook of Hypertension, Blackwell Scientific Publication.— London, 1994.

[11] Dzau V.J.// J. Cardiovasc. Pharmacol. — 1989. - Vol. 14. - P. S1-S5.

[12] Egan B.M., Schork N, Panis R, Hinderliter A.// J. Hypertens. — 1988. — Vol. 6. — P. 41—48.

[13] Ferrara L.A., Mancini M., Celentano A. et al.// Arterioscler. Thromb. — 1994. — Vol. 14. — P. 1290-1296.

[14] Folkov B.//Physioï. Rev. — 1982. — Vol. 62. — P. 347-504.

[15] Giaconi S., Lev anti C., Fommei E. et al.// Am. J. Hypertens. - 1989. - Vol. 2. - P. 259-261.

[16] Gibbons G.H., Dzau KJ.//Cardiovasc. Drugs Ther. - 1990. - Vol. 4. - P. 237-242.

[17] Hogan R.D., Hirshman L.// Microvasc. Res. — 1984. - Vol. 27. - P. 290-296.

[18] Hughes A.D., Sinclair A.-M., Geroulakos G. et al.// J. Hum. Hypertens. — 1993. — Vol. 7. — P. 395-397.

[19] Hutchins P.M., Darnell A.E.// Cire. Res. — 1974. - Vol. 34/35- P. 161-165.

[20] Inagami T.// Essays Biochem. — 1994. — Vol. 28. - P. 147—164.

[21] Inman S.R., Brouhard B.H., Stowe N.T.// Cleve. Clin. J. Med. - 1994. - Vol. 61. - P. 179-185.

[22] Johnston CI//}. Hypertens. - 1992. - Vol. 10. - S13- S26.

[23] Jonsson J.R., Game P.A., Head R.J. et al.// Blood Pressure. — 1994. — Vol. 3. — P. 72—75.

[24] Larochelle P.// Am. Heart. J. — 1991. — Vol. 122. - P. 1228-1231.

[25] Leung D.Y.M., Glagov S., Mathews M.B.// Science. - 1976. - Vol. 191. - P. 475-477.

[26] Levy D., Garrison R.J. et al.// N. Engl. J. Med. - 1990. - .Vol. 322. - P. 1561-1566.

[27] Liao Y., Husain A.// Can. J. Cardiol. — 1995. — Vol. 11. - P. 13F-19F.

[28] Lindeman R.D., Tobin J.D., Shock N.W// Kidney Int. — 1984. — Vol. 26. — P. 861—868.

[29] Meredith P.A., Elliott H.L. Optimal blood pressure control. Science Press., 1996.

[30] Metcalf P.A., Scragg R.K// J. Diab. Compile. - 1994. - Vol. 8. - P. 157-163.

[31] Mimran A., Ribstein J. et al.// J. Diabet. Complic. - 1994. - Vol. 8. - P. 150-156.

[32] Moalic J.M., Bauters C, Himbert D. et al.// J. Hypertens. — 1989. — Vol. 7. — P. 195—201.

[33] Mulvany M.J.// Eur. Heart J. — 1993. — Vol. 14. - P. 2-4.

[34] Naftilan A.J., Pratt R.E., Dzau V.J.//}. Clin. Invest. - 1989. - Vol. 83. - P. 1419-1424.

[35] Nordländer M. Target organs in hypertension: the vascular tree. In: Messerli F. (ed). The ABC's of Antihypertensive Therapy, Author ' Publishing House, N.-Y., 1994.

[36] Ohya Y, Sperelakis N.// Circ. Res. — 1991. — Vol. 68. - P. 763-771.

[37] Olinic M., Vida-Smiti L., Cristea A., Muresan A// Rom. J. Intern. Med. — 1994. — Vol. 32. — P. 7—21.

[38] Opie L. Angiotensin converting enzyme inhibitors. Authors Publishing House, N.-Y., 1992.

[39] О Rourke M.// Hypertension. — 1990. — Vol. 15. - P. 339-347.

[40] Pedrinelli RA., Giampetro O., Carmassi F. et al./ /Lancet. - 1994. - Vol. 344. - P. 14-18.

[41] Prewitt R.L., Hashimoto H, Stacy D.L.//In: Lee R., ed. Blood vessel changes in hypertension: structure and function. Boca Raton, Florida: CRC Press, 1990.

[42] Redon J., Miralles A., Lurbe E. et al.// Med. Clin. Bare. - 1995. - Vol. 104. -P. 608-611.

[43] Roman M., Pickering T, Pini R. et al.// Hypertension. — 1995. — Vol. 26. — P. 369—373.

[44] Ruilope L.M., Alcazar J.M., Rodicio J.L.// J. Hypertens. - 1992. - Vol. 10. - P. 85-90.

[45] Ruilope L.M., Lahera V., Rodicio J.L. et al.// Hypertension. — 1994. — Vol. 23. — P. 3—9.

[46] Ruilope L.M., Rodicio J.L.// Kidney Curr. Surv. World Literature. — 1995. — Vol. 4. — P. 211—216.

[47] Safar M.E., London G.M.// Hypertension. — 1987. - Vol. 10. - P. 133-139.

[48] Schiffrin E., Deng L.Y.// J. Hypertens. — 1996. - Vol. 14. - P. 1247-1255.

[49] Schmieder R.E., Veelken R. et al.//}. Hypertens. - 1995. - Vol. 13. - P. 357-365.

[50] Schwartz S.M., Liaw L.// Cardiovasc. Pharmacol. - 1993. - Vol. 21. - P. 31-50.

[51] Shichiri M., Hirata Y., Ando K. et al.//Hypertension. — 1990. — Vol. 15. — P. 493—496.

[52] Sihm I.// Br. J. Cardiol. — 1995. — Vol. 2. — P. 11-12.

[53] Sivertsson R.// Acta Physiol. Scand. — 1970. — Suppl. 343. - P. 1-56.

[54] Stribma J., Englis M. et al.// Cas. Lek. Ces. — 1995. - Vol. 134. - P. 749-751.

[55] Struijker Boudier H.A.J. In: Swales J.D. (ed), Textbook of Hypertension, Blackwell Scientific Publication. — London, 1994.

[56] Thom 5//Br. J. Cardiol. — 1995. — Vol. 2. — P. 10.

[57] Tierney W.M., Harris L.E. et al.// Am. J. Hypertens. — 1990. — Vol. 3. — P. 69—75.

[58] Zancetti A., Leonetti G.//. Cardiovasc. Pharmacol. - 1985. - Vol. 4. - P. 433-437.

RIGHTS & PERMISSIONS

Eco-Vector